Weed ETF waives fee ahead of much-awaited drug relabeling

Weed ETF waives fee ahead of much-awaited drug relabeling
The sector-focused fund will sport a zero percent expense ratio for a limited time as regulators move to reclassify the substance.
JUL 01, 2024
By  Bloomberg

Roundhill Investments is completely waiving the fee for its $5.6 million cannabis fund as US regulators move to reclassify marijuana as a less dangerous substance.

Starting Monday, the actively managed Roundhill Cannabis ETF (ticker WEED) is dropping its expense ratio to zero from 40 basis points for at least one year, according to a filing submitted to the US Securities and Exchange Commission last week. 

“With the likely upcoming reclassification of cannabis to a Schedule III drug potentially serving as a catalyst for the space, Roundhill is offering this fee waiver for the WEED ETF to make investing in cannabis more accessible,” said David Mazza, Roundhill’s chief executive officer. 

The Department of Justice in May had formally started the procedure of shifting marijuana’s legal status to Schedule III, less dangerous, from Schedule I, most dangerous, a move that’s been backed by President Joe Biden. 

WEED has lost 58% since its April 20, 2022 inception — a date celebrated among cannabis aficionados every year — but has notched a nearly 5% gain year to date.

Still, the dozen exchange-traded funds linked to cannabis and psychedelics tracked by Bloomberg Intelligence have seen 17 consecutive monthly inflows, with investors plowing $393 million into them this year alone. The largest in the group is the $889 million AdvisorShares Pure US Cannabis ETF (MSOS), launched in September 2020, which has an expense ratio of 74 basis points.

The long-awaited step toward potential acceptance of marijuana is widely viewed as a victory for the industry, with many anticipating significant benefits, from reduced civil and criminal penalties to tax advantages. No decision has been made yet and reclassifying cannabis will not decriminalize it. 

Latest News

Record growth: Interval funds emerge as key players in alternative investments
Record growth: Interval funds emerge as key players in alternative investments

Blue Vault Alts Summit highlights the role of liquidity-focused funds in reshaping advisor strategies

SignatureFD welcomes M&A veteran Peter Nesvold to board
SignatureFD welcomes M&A veteran Peter Nesvold to board

The $9.1 billion RIA is tapping into Nesvold's decades of leadership, including his time at Silver Lane Advisors and Bear Stearns, for its next leg of thoughtful expansion.

For two-fifths of modern couples, commitment is spelled with joint insurance
For two-fifths of modern couples, commitment is spelled with joint insurance

Survey of renting couples finds joint policies on par with traditional milestones, including moving in together and their first "I love you," as a means to cement relationships.

How pro bono planning creates a practice management edge
How pro bono planning creates a practice management edge

Finding purpose, skills enhancement, and attracting new talent are just a few potential benefits for altruistic planners and the firms that support them.

SEC moves to keep ESG shareholder resolutions off proxy ballots
SEC moves to keep ESG shareholder resolutions off proxy ballots

The agency is reverting to a Trump-era policy that allowed public companies to widely exclude environmentally and socially themed resolutions.

SPONSORED Record growth: Interval funds emerge as key players in alternative investments

Blue Vault Alts Summit highlights the role of liquidity-focused funds in reshaping advisor strategies

SPONSORED Taylor Matthews on what's behind Farther's rapid growth

From 'no clients' to reshaping wealth management, Farther blends tech and trust to deliver family-office experience at scale.